BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10433485)

  • 1. Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation.
    Kim HS; Zhang YH; Fang LH; Yun YP; Lee HK
    J Ethnopharmacol; 1999 Aug; 66(2):241-6. PubMed ID: 10433485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M; Zhang LZ; Lu JS
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bakkenolide G, a natural PAF-receptor antagonist.
    Liao CH; Ko FN; Wu TS; Teng CM
    J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation.
    Kim HS; Zhang YH; Yun YP
    Planta Med; 1999 Mar; 65(2):135-8. PubMed ID: 10193204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
    Chen YY; Kwan CY; Hui SC
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma.
    Ko FN; Lee YS; Kuo SC; Chang YS; Teng CM
    Biochim Biophys Acta; 1995 Sep; 1268(3):329-34. PubMed ID: 7548232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of tetrandrine on rabbit platelet aggregation, thromboxane A2 generation and calmodulin activity].
    Qian YM; Huang YH
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):61-5. PubMed ID: 2816404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of G619, a new platelet aggregation inhibitor.
    Yue TL; Smith EF; Ohlstein EH; Sulpizio A; Slivjak MJ; Rabinovici R; Sellers TS; Lynch KM; Poyser R; Feuerstein G
    Thromb Res; 1992 May; 66(4):331-47. PubMed ID: 1412200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats].
    Huang HL; Rao MR
    Yao Xue Xue Bao; 1995; 30(7):486-90. PubMed ID: 7484155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat.
    Kim HS; Zhang YH; Oh KW; Ahn HY
    J Ethnopharmacol; 1997 Oct; 58(2):117-23. PubMed ID: 9406900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
    Chou TC; Hsu LY; Yen MH; Ding YA
    Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activating factor production in bovine cerebral microvascular endothelial cells and its drug inhibition.
    Sun DX; Huang TG; Zeng GQ; Rui YC
    Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):26-30. PubMed ID: 8503282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb.
    Hsiao G; Ko FN; Jong TT; Teng CM
    Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
    Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of trilobine on platelet aggregation, thromboxane A2, and prostacyclin formation in rats].
    Tan JQ; Chu ZX; Shen FM; Liang HQ; Chen HS
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):375-7. PubMed ID: 1807088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation.
    Chen WY; Ko FN; Lin CN; Teng CM
    Thromb Res; 1994 Jul; 75(1):81-90. PubMed ID: 8073410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.